These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 28087588)
21. The score is in but is the decision final? Brinker J J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596 [No Abstract] [Full Text] [Related]
22. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Mehran R; Rao SV; Bhatt DL; Gibson CM; Caixeta A; Eikelboom J; Kaul S; Wiviott SD; Menon V; Nikolsky E; Serebruany V; Valgimigli M; Vranckx P; Taggart D; Sabik JF; Cutlip DE; Krucoff MW; Ohman EM; Steg PG; White H Circulation; 2011 Jun; 123(23):2736-47. PubMed ID: 21670242 [No Abstract] [Full Text] [Related]
23. The year in non-ST-segment elevation acute coronary syndrome. Giugliano RP; Braunwald E J Am Coll Cardiol; 2008 Sep; 52(13):1095-103. PubMed ID: 18848144 [No Abstract] [Full Text] [Related]
24. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs). Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703 [TBL] [Abstract][Full Text] [Related]
25. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. Elbarouni B; Elmanfud O; Yan RT; Fox KA; Kornder JM; Rose B; Spencer FA; Welsh RC; Wong GC; Goodman SG; Yan AT Am Heart J; 2010 Sep; 160(3):420-7. PubMed ID: 20826248 [TBL] [Abstract][Full Text] [Related]
26. Anticoagulants and antiplatelet therapy: 2012 update. Cummins D J Ark Med Soc; 2012 Aug; 109(2):39. PubMed ID: 22984709 [No Abstract] [Full Text] [Related]
28. Impact of Glycoprotein IIb/IIIa Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the National Cardiovascular Data Registry. Safley DM; Venkitachalam L; Kennedy KF; Cohen DJ JACC Cardiovasc Interv; 2015 Oct; 8(12):1574-82. PubMed ID: 26493250 [TBL] [Abstract][Full Text] [Related]
29. Prasugrel for acute coronary syndromes: faster, more potent, but higher bleeding risk. Lazar LD; Lincoff AM Cleve Clin J Med; 2009 Dec; 76(12):707-14. PubMed ID: 19952295 [TBL] [Abstract][Full Text] [Related]
30. Safety of glycoprotein IIb/IIIa inhibitors in patients under therapeutic hypothermia admitted for an acute coronary syndrome. Jiménez-Brítez G; Freixa X; Flores E; Penela D; Hernandez-Enríquez M; San Antonio R; Caixal G; Garcia J; Roqué M; Martín V; Brugaletta S; Masotti M; Sabaté M Resuscitation; 2016 Sep; 106():108-12. PubMed ID: 27449822 [TBL] [Abstract][Full Text] [Related]
31. Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation. Vavalle JP; Rao SV Adv Cardiol; 2012; 47():125-40. PubMed ID: 22906908 [TBL] [Abstract][Full Text] [Related]
32. The clinical and economic impact of bivalirudin for percutaneous coronary intervention. Malik N; Gershlick AH Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):699-706. PubMed ID: 24219045 [TBL] [Abstract][Full Text] [Related]
33. A risk score to predict bleeding in patients with acute coronary syndromes. Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595 [TBL] [Abstract][Full Text] [Related]
34. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study). Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470 [TBL] [Abstract][Full Text] [Related]
35. Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes. Gutierrez A; Rao SV Cleve Clin J Med; 2010 Jun; 77(6):369-79. PubMed ID: 20516248 [TBL] [Abstract][Full Text] [Related]
36. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. ; Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Eikelboom JW; Fox KA; Granger CB; Jolly S; Joyner CD; Rupprecht HJ; Widimsky P; Afzal R; Pogue J; Yusuf S N Engl J Med; 2010 Sep; 363(10):930-42. PubMed ID: 20818903 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes. De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863 [TBL] [Abstract][Full Text] [Related]
38. [Combination of anticoagulants with platelet aggregation inhibitors?]. Schieber M; Sechtem U Dtsch Med Wochenschr; 2005 Nov; 130(47):2725. PubMed ID: 16294291 [No Abstract] [Full Text] [Related]
39. Bleeding and outcome in acute coronary syndrome: insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial. Yan AT; Yan RT; Huynh T; DeYoung P; Weeks A; Fitchett DH; Langer A; Goodman SG; Am Heart J; 2008 Oct; 156(4):769-75. PubMed ID: 18926160 [TBL] [Abstract][Full Text] [Related]
40. Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR]). Damman P; Varenhorst C; Koul S; Eriksson P; Erlinge D; Lagerqvist B; James SK Am J Cardiol; 2014 Jan; 113(1):64-9. PubMed ID: 24169009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]